BLFE — Biolife Sciences Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.32m
- $0.61m
Annual cashflow statement for Biolife Sciences, fiscal year end - November 30th, USD millions except per share, conversion factor applied.
2010 November 30th | 2011 November 30th | 2012 November 30th | 2020 November 30th | 2021 November 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | 10-K | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1.72 | -0.293 | -0.202 | -1.27 | -0.457 |
| Amortisation | |||||
| Non-Cash Items | 0.041 | 0.227 | 0.153 | 0.004 | 0.162 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0 | 0.013 | 0.013 | 0.263 | 0.188 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | 1.76 | -0.04 | -0.037 | -1 | -0.107 |
| Capital Expenditures | — | — | — | -0.001 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.545 | 0 | 0 | — | — |
| Acquisition of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.545 | 0 | 0 | -0.001 | 0 |
| Financing Cash Flow Items | -1.53 | 0.037 | 0.034 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1.22 | 0.038 | 0.034 | 0.989 | 0.075 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.004 | -0.002 | -0.003 | 0.035 | -0.018 |